1. Reynolds M. What is coronavirus and how close is it to becoming a pandemic? Wired UK ISSN. 2020:1357-0978.

2. Wake AD. The willingness to receive COVID-19 vaccine and its associated factors:"vaccination refusal could prolong the war of this pandemic"-a systematic review. Risk management and healthcare policy. 2021;14:2609. [DOI:10.2147/RMHP.S311074] [PMID] []

3. Muhajarine N, Adeyinka DA, McCutcheon J, Green KL, Fahlman M, Kallio N. COVID-19 vaccine hesitancy and refusal and associated factors in an adult population in Saskatchewan, Canada: Evidence from predictive modelling. PloS one. 2021;16(11):e0259513. [DOI:10.1371/journal.pone.0259513] [PMID] []

4. Graichen H. What is the difference between the first and the second/third wave of Covid-19?-German perspective. Elsevier; 2021. p. A1-A3. [DOI:10.1016/j.jor.2021.01.011] [PMID] []

5. WHO. WHO Coronavirus (COVID-19) Dashboard: World Health Organization; [Available from: https://covid19.who.int/.

6. Hesni E, Sayad B, Khosravi Shadmani F, Najafi F, Khodarahmi R, Rahimi Z, et al. Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study. BMC Infectious Diseases. 2022;22(1):1-12. [DOI:10.1186/s12879-022-07312-7] [PMID] []

7. Jin L. Iran's COVID-19 fight: Domestic and external implications. Asian Journal of Middle Eastern and Islamic Studies. 2020:1-12. [DOI:10.1080/25765949.2020.1808374]

8. Ghotbi N. The COVID-19 Pandemic Response and Its Impact on Post-Corona Health Emergency and Disaster Risk Management in Iran. Sustainability. 2022;14(22):14858. [DOI:10.3390/su142214858]

9. Looi M-K. How are covid-19 symptoms changing? bmj. 2023;380. [DOI:10.1136/bmj.p3] [PMID]

10. Iftimie S, López-Azcona AF, Lozano-Olmo MJ, Hernández-Aguilera A, Sarrà-Moretó S, Joven J, et al. Characteristics of hospitalized patients with SARS-CoV-2 infection during successive waves of the COVID-19 pandemic in a reference hospital in Spain. 2022;12. [DOI:10.1038/s41598-022-22145-9] [PMID] []

11. Martinot M, Eyriey M, Gravier S, Ion C, Mohseni-Zadeh M, Rougier E, et al. Characteristic and outcome changes in inpatients with COVID-19 during the four pre - Omicron waves. 2023;27 1:1-6.

12. Haghighi M, Khoshrang H, Ghazanfar Tehran S, Aghajanzadeh P, Jafarinezhad A, Souri Z, et al. Evaluation of Epidemiological, Paraclinical, and Imaging Findings of Patients With‎ Covid-19 Hospitalized in Intensive Care Unit of Rasht Hospitals in March 2020. Journal of Guilan University of Medical Sciences. 2021;30(2):84-97. [DOI:10.32598/JGUMS.30.2.1619.2]

13. Rovida F, Esposito GL, Rissone M, Novelli V, Cutti S, Muzzi A, et al. Characteristics and outcomes of vaccinated and nonvaccinated patients hospitalized in a single Italian hub for COVID-19 during the Delta and Omicron waves in Northern Italy. International Journal of Infectious Diseases. 2022;122:420-6. [DOI:10.1016/j.ijid.2022.06.028] [PMID] []

14. Fano-Sizgorich D, Vásquez-Velásquez C, Orellana LR, Ponce-Torres C, Gamboa-Serpa H, Alvarez-Huambachano K, et al. Risk of death, hospitalization and intensive care unit admission by SARS-CoV-2 variants in Peru: a retrospective study. International Journal of Infectious Diseases. 2023;127:144-9. [DOI:10.1016/j.ijid.2022.12.020] [PMID] []

15. Sadeghi F, Halaji M, Shirafkan H, Pournajaf A, Ghorbani H, Babazadeh S, et al. Characteristics, outcome, duration of hospitalization, and cycle threshold of patients with COVID-19 referred to four hospitals in Babol City: a multicenter retrospective observational study on the fourth, fifth, and sixth waves. BMC Infectious Diseases. 2024;24(1):55. [DOI:10.1186/s12879-023-08939-w] [PMID] []

16. Freund O, Tau L, Weiss TE, Zornitzki L, Frydman S, Jacob G, et al. Associations of vaccine status with characteristics and outcomes of hospitalized severe COVID-19 patients in the booster era. 2022;17. [DOI:10.1371/journal.pone.0268050] [PMID] []

17. Jesmani Y, Bozorgomid A, Shadmani FK, Dehbani A, Sayad B. Demographic and clinical characteristics and outcomes of COVID-19 patients admitted to a university hospital in the west of Iran: a retrospective study in the third wave. Vacunas. 2023. [DOI:10.1016/j.vacun.2023.01.005] [PMID] []

18. Fattahi Z, Mohseni M, Beheshtian M, Jafarpour A, Jalalvand K, Keshavarzi F, et al. Disease Waves of SARS-CoV-2 in Iran Closely Mirror Global Pandemic Trends. 2022;25(8):508-22. [DOI:10.34172/aim.2022.83] [PMID]

19. Shirafkan H, Sadeghi F, Halaji M, Rahmani R, Yahyapour Y. Demographics, clinical characteristics, and outcomes in hospitalized patients during six waves of COVID‑19 in Northern Iran: a large cohort study. Sci Rep. 2023;13(1):22527. [DOI:10.1038/s41598-023-50139-8] [PMID] []

20. Hadadi A, Pirzadeh M, Kazemian S, Ashraf H, Ebrahimi M, Karbalai Saleh S, et al. COVID-19 in Iran: clinical presentations and outcomes in three different surges of COVID-19 infection. Virology Journal. 2022;19(1):1-8. [DOI:10.1186/s12985-022-01846-7] [PMID] []

21. Heydarifard Z, Shafiei-Jandaghi NZ, Safaei M, Tavakoli F, Shatizadeh Malekshahi S. Comparison of clinical outcomes, demographic, and laboratory characteristics of hospitalized COVID-19 patients during major three waves driven by Alpha, Delta, and Omicron variants in Tehran, Iran. Influenza and other respiratory viruses. 2023;17(8):e13184. [DOI:10.1111/irv.13184] [PMID] []

22. Salehi M, Salami Khaneshan A, Farahani AS, Doomanlu M, Arabzadeh M, Sobati A, et al. Characteristics and outcomes of COVID-19 patients during the BA. 5 omicron wave in Tehran, Iran: a prospective observational study. BMC Infectious Diseases. 2023;23(1):237. [DOI:10.1186/s12879-023-08181-4] [PMID] []

23. Allameh SF, Nemati S, Ghalehtaki R, Mohammadnejad E, Aghili SM, Khajavirad N, et al. Clinical Characteristics and Outcomes of 905 COVID-19 Patients Admitted to Imam Khomeini Hospital Complex in the Capital City of Tehran, Iran. Archives of Iranian medicine. 2020;23(11):766-75. [DOI:10.34172/aim.2020.102] [PMID]

24. Payvar B, Azami S, Khodadadegan M, Saburi E, Sahab Negah S, Hajali V. Clinical Symptoms of COVID-19 Patients admitted to Hazrat Musa Ibne Jafar Hospital in Quchan City. Navid No. 2022;25(83):11-7.

25. Marquez C, Kerkhoff AD, Schrom J, Rojas S, Black D, Mitchell A, et al. COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods. JAMA network open. 2022;5(10):e2235844. [DOI:10.1001/jamanetworkopen.2022.35844] [PMID] []

26. Abbasi-Ghahramanloo A, Pourfarzi F, Nakhostin B, Emdadi D, Abishvand J, Biria M, et al. Trends in Clinical Symptoms of Novel Coronavirus Disease (COVID-19) in the Northwest of Iran. 2020. [DOI:10.21203/rs.3.rs-135517/v1]

27. Schulze H, Bayer W. Changes in symptoms experienced by SARS-Cov-2-infected individuals-from the first wave to the Omicron variant. Frontiers in Virology. 2022;2. [DOI:10.3389/fviro.2022.880707]

28. Vihta KD, Pouwels KB, Peto TE, Pritchard E, House T, Studley R, et al. Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2022;76(3):e133-41. [DOI:10.1093/cid/ciac613] [PMID] []

29. Ciaffi J, Meliconi R, Ruscitti P, Berardicurti O, Giacomelli R, Ursini FJBR. Rheumatic manifestations of COVID-19: a systematic review and meta-analysis. 2020;4. [DOI:10.1186/s41927-020-00165-0] [PMID] []

30. 30. Hujamberdieva LM, Chimed-Ochir O, Yumiya Y, Tanaka J, Ohge H, Kuwabara M, et al. Relationship between clinical symptom profiles and COVID-19 infection status during delta-dominant period versus omicron-dominant period - analysis of real-world data collected in Hiroshima Prefecture, Japan. 2023. [DOI:10.1016/j.ijid.2023.09.007] [PMID]

31. Zali A, Khodadoost M, Gholamzadeh S, Janbazi S, Piri H, Taraghikhah N, et al. Mortality among hospitalized COVID-19 patients during surges of SARS-CoV-2 alpha (B. 1.1. 7) and delta (B. 1.617. 2) variants. Scientific Reports. 2022;12(1):18918. [DOI:10.1038/s41598-022-23312-8] [PMID] []

32. Santos RS, Barros DS, Moraes TMP, Hayashi CY, Ralio RB, Minenelli FF, et al. Clinical characteristics and outcomes of hospitalized patients with COVID-19 in a Brazilian hospital: a retrospective study of the first and second waves. IJID regions. 2022;3:189-95. [DOI:10.1016/j.ijregi.2022.04.002] [PMID] []

33. Iftimie S, López-Azcona AF, Lozano-Olmo MJ, Hernández-Aguilera A, Sarrà-Moretó S, Joven J, et al. Differential features of the fifth wave of COVID-19 associated with vaccination and the Delta variant in a reference hospital in Catalonia, Spain. 2021:2021.10. 14.21264933. [DOI:10.1101/2021.10.14.21264933]

34. Li J-X, Liao P-L, Wei JC-C, Hsu S-B, Yeh C-JJFiPH. A chronological review of COVID-19 case fatality rate and its secular trend and investigation of all-cause mortality and hospitalization during the Delta and Omicron waves in the United States: a retrospective cohort study. 2023;11:1143650. [DOI:10.3389/fpubh.2023.1143650] [PMID] []

35. Elimian K, Musah A, King C, Igumbor E, Myles P, Aderinola O, et al. COVID-19 mortality rate and its associated factors during the first and second waves in Nigeria. 2022;2(6):e0000169. [DOI:10.1371/journal.pgph.0000169] [PMID] []

36. Emani VR, Nakka AS, Goswami KK, Emani SR, Maddula KR, Reddy NK, et al. Changing dynamics of SARS-CoV2 B. 1.617. 2 (Delta variant) outbreak in the United Kingdom: Shifting of SARS-CoV2 infections from younger to elderly populations with increasing hospitalizations and mortality among elderly. 2022:2022.03. 05.22271084. [DOI:10.1101/2022.03.05.22271084]

37. Serwatyari K, Zamanimahr N, Rahmani K. Investigaton of the factors related to the prolongation of the fifth peak of COVID-19 in Kurdistan Province, Iran: a qualitative study. 2022. [DOI:10.52547/sjku.27.4.53]

38. Dyer OJB. Covid-19: Unvaccinated face 11 times risk of death from delta variant, CDC data show. 2021;374(2282). [DOI:10.1136/bmj.n2282] [PMID]

39. Pedhambkar R, Salgotra K, Bhusare DBJIJOCM, Health P. COVID-19 vaccination: disease status and outcomes of COVID-19 patients admitted in tertiary care hospital in Raigad District of Maharashtra. 2024. [DOI:10.18203/2394-6040.ijcmph20240891]

40. Selvavinayagam DTS, Parthipan DK, Subramaniam DS, Somasundaram DA, Sampath D, Kumar DV, editors. Role of Covid vaccine in determining ICU admission and death due to Covid -19 in Tamil Nadu. medRxiv; 2022. [DOI:10.1101/2022.02.07.22270596]

41. Demir İ, Yılmaz RS, Köse B, Özkarakaş H, Çalık ŞJTERJ. Relationships between vaccination, age, and mortality in the COVID-19 intensive care patients. 2022;8(6):783-9. [DOI:10.18621/eurj.1071588]

42. Taylor K, Rivere E, Jagneaux T, LeBoeuf G, Estela K, Pierce C, et al. Clinical characteristics and outcomes of SARS-Cov-2 B.1.1.529 infections in hospitalized patients and multi-surge comparison in Louisiana. PLoS One. 2022;17(10):e0268853. [DOI:10.1371/journal.pone.0268853] [PMID] []

43. Li J-X, Liao P-L, Wei JC-C, Hsu S-B, Yeh C-JJFiPH. A chronological review of COVID-19 case fatality rate and its secular trend and investigation of all-cause mortality and hospitalization during the Delta and Omicron waves in the United States: a retrospective cohort study. 2023;11. [DOI:10.3389/fpubh.2023.1143650] [PMID] []

44. Tabatabai MA, Juarez PD, Matthews-Juarez P, Wilus D, Ramesh A, Alcendor DJ, et al. An Analysis of COVID-19 Mortality During the Dominancy of Alpha, Delta, and Omicron in the USA. 2023;14. [DOI:10.1177/21501319231170164] [PMID] []

45. Reum Kim A, Lee J, Park SJ, Kang SW, Lee YW, Lim SY, et al. 259. Comparison of the causes of death in patients with delta variant versus omicron variant infections. 2022;9. [DOI:10.1093/ofid/ofac492.337] []

46. Wrenn JO, Pakala SB, Vestal G, Shilts MH, Brown HM, Bowen SM, et al. COVID‐19 severity from Omicron and Delta SARS‐CoV‐2 variants. 2022;16:832 - 6. [DOI:10.1111/irv.12982] [PMID] []

47. Miyashita K, Hozumi H, Furuhashi K, Nakatani E, Inoue Y, Yasui H, et al. Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study. Emerging Microbes & Infections. 2023;12(1):2155250. [DOI:10.1080/22221751.2022.2155250] [PMID] []

48. Butt AA, Dargham SR, Chemaitelly H, Al Khal A, Tang P, Hasan MR, et al. Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar. JAMA internal medicine. 2022;182(2):197-205. [DOI:10.1001/jamainternmed.2021.7949] [PMID] []

49. Ajmera P, Kharat A, Dhirawani S, Khaladkar S, Kulkarni V, Duddalwar V, et al. Evaluating the Association Between Comorbidities and COVID-19 Severity Scoring on Chest CT Examinations Between the Two Waves of COVID-19: An Imaging Study Using Artificial Intelligence. Cureus. 2022;14. [DOI:10.7759/cureus.21656]

50. Balacchi C, Brandi N, Ciccarese F, Coppola F, Lucidi V, Bartalena L, et al. Comparing the first and the second waves of COVID-19 in Italy: differences in epidemiological features and CT findings using a semi-quantitative score. Emergency radiology. 2021;28(6):1055-61. [DOI:10.1007/s10140-021-01937-y] [PMID] []

51. Flisiak R, Rzymski P, Zarębska-Michaluk D, Ciechanowski P, Dobrowolska K, Rogalska M, et al. Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database. Viruses. 2023;15(1). [DOI:10.3390/v15010149] [PMID] []

52. Trecarichi EM, Olivadese V, Davoli C, Rotundo S, Serapide F, Lionello R, et al. Evolution of in-hospital patient characteristics and predictors of death in the COVID-19 pandemic across four waves: are they moving targets with implications for patient care? Front Public Health. 2023;11:1280835. [DOI:10.3389/fpubh.2023.1280835] [PMID] []

53. Heidari M, Sayfouri N, Jafari H. Consecutive Waves of COVID-19 in Iran: Various Dimensions and Probable Causes. Disaster medicine and public health preparedness. 2022;17:e136. [DOI:10.1017/dmp.2022.45] [PMID] []